CSL News: uniQure announces the European Commission approval of the first gene therapy for adults with hemophi - 21st Feb 2023, 11:05pm

annb0t

Top 20
uniQure Inc.

~ Historic approval represents the first gene therapy in Europe to treat hemophilia B and provides a new treatment option for patients that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels ~

~ Approval marks uniQure’s second internally-developed and manufactured gene therapy to achieve licensure in the European Union ~

LEXINGTON, Mass. and AMSTERDAM, Feb. 21, 2023 (GLOBE NEWSWIRE...

>>> Read more: uniQure announces the European Commission approval of the first gene therapy for adults with hemophilia B
 
Top Bottom